NPPB and hydrops fetalis: Moreover, as reported by Jannuzzi et al. in the PROVE-HF study, the reduction in NT-proBNP levels in HFrEF patients following treatment with sac/val was associated, after 12 months, with a positive change of several cardiac remodelling measures (Januzzi JL Jr, et al., 2019).